Yaxin Hou

Yaxin Hou


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2016 in Current Organic Chemistry
Verified
Journal Article
Closed access
ZWZuojun Wei
Zuojun Wei
YHYaxin Hou
Yaxin Hou
YYYao Yang
Yao Yang
YLYingxin Liu
Yingxin Liu
Graphene is an atomically thin, two-dimensional allotrope of carbon with excellent chemical, mechanical, and electronic properties. Recent studies have revealed that using graphene or modified graphene as a catalyst support or metal-free catalyst can result in significant improvement in the catalytic activity, selectivity, reusability and tolerance due to the unique structure of graphene. This review summarized the recent progress on the preparation of the graphene-based catalysts and their application in traditional chemical reactions, electrochemical reactions and photochemical catalysis. The perspectives of achieving graphene-based catalysts with high catalytic performance have also been included.

30 November 2024 in Bioresource Technology
Verified
Journal Article
Closed access
YHYaxin Hou
Yaxin Hou
RZRong Zhao
Rong Zhao
JMJun Ma
Jun Ma
KJKeqing Jia
Keqing Jia
AAAbuliti Abudula
Abuliti Abudula
YDYun Duan
Yun Duan

10 November 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YLYang Li
Yang Li
PSPengjie Shi
Pengjie Shi
YDYuhong Ding
Yuhong Ding
ZYZhipeng Yao
Zhipeng Yao
LLLilong Liu
Lilong Liu
YHYaxin Hou
Yaxin Hou
Bladder cancer (BC) is a prevalent malignancy characterized by significant cellular heterogeneity. While single-cell multi-omics studies have provided valuable insights, much of the existing data remains underexplored, limiting our understanding of BC’s molecular mechanisms. Uncovering the pathogenesis of BC and finding new treatment methods are urgent problems to be solved. This study aims to address this gap by re-analyzing available single-cell datasets to uncover novel insights into BC. In this study, we retrieved three single-cell transcriptome datasets by searching the Gene Expression Omnibus (GEO) database, focusing on single-cell sequencing of normal mouse bladder within the past 5 years. Through quality control and batch effect elimination, we obtained a total of 24,930 cells including epithelial, stromal, and immune cells. Subgroup analysis, pseudotemporal analysis, cell–cell communication, and transcription factor analysis were conducted specifically on epithelial cells to identify a transitional state during basal cell differentiation. We further compared the expression profiles of key transcription factors in cancer and normal tissues. In addition, we also performed immunohistochemical staining and survival analysis for key transcription factors. Subgroup analysis revealed multiple subtypes of epithelial cells, including basal, umbrella, and intermediate cells. Through pseudotemporal analysis, we discovered the developmental trajectory from basal cells to umbrella cells and further found that Basal_I is a transitional state for basal cell differentiation. Cell-to-cell communication analyses highlighted the pivotal role of Basal_I in cell–cell interactions, and key ligand-receptor pairs associated with cancer progression were also identified. Furthermore, elevated expression levels of key transcription factors in Basal_I were found to be closely associated with the stage and prognosis of BC. Immunohistochemical staining results further confirmed the upregulated expression of these transcription factors in BC. Collectively, we found a transitional state of basal cells in normal bladder epithelial cells in mice, which may be related to the occurrence and development of BC, providing important clues for further understanding of the pathogenesis of BC. Our study provided possible molecular mechanisms or target for the research and treatment of BC.

24 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
LLLilong Liu
Lilong Liu
KLKaiwen Li
Kaiwen Li
Shaogang WangShaogang Wang
Shaogang Wang
CCChinese Bladder Cancer Consortium
Chinese Bladder Cancer Consortium
JWJianli Wang
Jianli Wang
KCKe Chen
Ke Chen
Objective: Most bladder cancers are nonmuscle invasive bladder cancer (NMIBC), and transurethral resection of bladder tumors (TURBT) is the standard treatment. However, postoperative recurrence remains a significant challenge, and the influence of bladder tumor location on prognosis is still unclear. This study aims to investigate how tumor location affects the prognosis of NMIBC patients undergoing TURBT and to identify the optimal surgical approach. Methods: A multicenter study was conducted, which included Chinese NMIBC data from 15 hospitals (1996–2019) and data from 17 registries of the Surveillance, Epidemiology, and End Results database (SEER) (2000–2020). Patients initially diagnosed with NMIBC and undergoing TURBT or partial cystectomy were analyzed, with cases lost to follow-up or with missing data excluded. The study investigated the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) among patients with different tumor locations. Kaplan–Meier, Cox regression, and propensity score matching methods were employed to explore the association between tumor location and prognosis. Stratified populations were analyzed to minimize bias. Results: This study included 118 477 NMIBC patients and highlighted tumor location as a crucial factor impacting post-TURBT prognosis. Both anterior wall and dome tumors independently predicted adverse outcomes in two cohorts. For anterior wall tumors, the Chinese cohort showed hazard ratios (HR) for OS of 4.35 (P<0.0001); RFS of 2.21 (P<0.0001); SEER cohort OS HR of 1.10 (P=0.0001); DSS HR of 1.13 (P=0.0183). Dome tumors displayed similar trends [Chinese NMIBC cohort OS HR of 7.91 (P<0.0001); RFS HR of 2.12 (P<0.0001); SEER OS HR of 1.05 (P=0.0087); DSS HR of 1.14 (P=0.0006)]. Partial cystectomy significantly improved the survival of dome tumor patients compared to standard TURBT treatment (P<0.01). Conclusion: This study reveals the significant impact of tumor location in NMIBC patients on the outcomes of TURBT treatment, with tumors in the anterior wall and bladder dome showing poor post-TURBT prognosis. Compared to TURBT treatment, partial cystectomy improves the prognosis for bladder dome tumors. This study provides guidance for personalized treatment and prognosis management for NMIBC patients.

1 March 2020 in SCIENTIA SINICA Vitae
Verified
Journal Article
Open access
Kelong FanKelong Fan
Kelong Fan
YHYaxin Hou
Yaxin Hou
RZRuoFei ZHANG
RuoFei ZHANG
XYXiYun YAN
XiYun YAN

15 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
CDChangqi Deng
Changqi Deng
CWChengcheng Wei
Chengcheng Wei
YHYaxin Hou
Yaxin Hou
MXMing Xiong
Ming Xiong
DNDong Ni
Dong Ni
ZCzhaohui chen
zhaohui chen
We carried out whole transcriptome sequencing (WTS) on the tumor and the matching adjacent normal tissues from five patients having Xp11 translocation renal cell carcinoma (RCC). This was performed in terms of obtaining more understanding of the genomic panorama and molecular basis of this cancer. To examine gene-regulatory networks in XP11 translocation RCC, variance expression analysis was carried out, followed by functional enrichment analysis. Gene Expression Omnibus (GEO) of Xp11 translocation RCC data was used to validate the results. As per inclusion criteria, a total of 1886 differentially expressed mRNAs (DEmRNAs), 56 differentially expressed miRNAs (DEmiRNAs), 223 differentially expressed lncRNAs (DElncRNAs), and 1764 differentially expressed circRNAs (DEcircRNAs) were found. KEGG enrichment study of DEmiRNA, DElncRNA, and DEcircRNA target genes identified the function of protein processing in the endoplasmic reticulum, lysosome, and neutrophil-mediated immunity. Three subnetwork modules integrated from the PPI network also revealed the genes involved in protein processing in the endoplasmic reticulum, lysosome, and protein degradation processes, which may regulate the Xp11 translocation RCC process. The ceRNA complex network was created by Cytoscape, which included three upregulated circRNAs, five upregulated lncRNAs, 24 upregulated mRNAs, and two downregulated miRNAs (hsa-let-7d-5p and hsa-miR-433-3p). The genes as a prominent component of the complex ceRNA network may be key factors in the pathogenesis of Xp11 translocation RCC. Our findings clarified the genomic and transcriptional complexity of Xp11 translocation RCC while also pointing to possible new targets for Xp11 translocation RCC characterization.